Difemetorex
| Difemetorex | |
|---|---|
 | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 295.4 g/mol [1] |
| Predicted LogP | 3.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C20H25NO [1] |
| IUPAC name | 2-(2-benzhydrylpiperidin-1-yl)ethanol [1] |
| SMILES | C1CCN(C(C1)C(C2=CC=CC=C2)C3=CC=CC=C3)CCO [1] |
| InChI | InChI=1S/C20H25NO/c22-16-15-21-14-8-7-13-19(21)20(17-9-3-1-4-10-17)18-11-5-2-6-12-18/h1-6,9-12,19-20,22H,7-8,13-16H2 [1] |
| InChIKey | UHZJPVXMMCFPNR-UHFFFAOYSA-N [1] |
Difemetorex (also known as Difemetorex, Difemetorexum, 2-(Diphenylmethyl)-1-piperidineethanol, BA-28289, Diphemetoxidine, Ba 28289;Diphemetoxidine, 3-(3,4-dimethylpiperazin-1-yl)propyl 2-hydroxy-2,2-diphenylacetate, 2-(2-Benzhydryl-piperidino)ethanol, JB 8035 or Brn 1651678) is a
Chemistry
Stereochemistry []
Difemetorex is a racemic mixture of the enantiomers.
| Stereoisomerism |
|---|
| Stereoisomer enumberation with rdkit |
Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 65607, Difemetorex. Accessed May 8, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/65607
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Difemetorex. UNII: O0417MPF6W. Global Substance Registration System. Accessed May 8, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/O0417MPF6W